NCT01261351|CompletedDMC
Study of Coagulation Activation Markers and Pre Eclampsia
PRESTIGE
Coagulation Activation Markers and Pre Eclampsia : Correlation With Complications
Loading search results
PRESTIGE
Coagulation Activation Markers and Pre Eclampsia : Correlation With Complications
Sponsor study identifier
Secondary identifiers
OTHER_GRANT · hospital clinical research program, French health ministry
OTHER · ID-RCB number, AFSSAPS
observational
300
1 country
1
Study Start
May 2010
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
June 2014
Actual (reported)Study Completion
June 2014
Actual (reported)The primary purpose of the trial is to evaluate coagulation activator markers in patients with pre eclampsia compared to control (normal pregnancy) and to correlate these markers with the severity of the pathology.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 2014
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 2010
Date type not reportedThis date has not been verified as actual or estimated.
October 26, 2010
Actual (reported)December 16, 2010
Actual (reported)June 2014
Actual (reported)June 2014
Actual (reported)Endogenous thrombin potential
comparison of Endogenous thrombin potential between patients with Preclampsia (PE) (at the moment of the diagnosis of PE) compared to control (at the same gestational age)
at preeclampsia diagnosis
genotype-phenotype correlation (Polymorphism of prostacyclin-synthetase promoter CYP8A1
at pre eclampsia diagnosis
In preeclampsia group : correlation between biological markers and severity of the disease
at the diagnosis of preeclampsia
evolution of endogenous thrombin potential in women with preeclampsia
between the diagnosis of preeclampsia and day 2 of the post partum period
pregnant women from two University hospitals in France
University Hospital of Lille
Lille, Nord, 59037, France
* Maternal blood and urine * cord blood
Véronique Houfflin Debarge, PHD
Universituy Hospital Of Lille, France
300 participants (actual enrollment reported by the registry).
First Submitted
October 26, 2010
First Posted
December 16, 2010
Study Start
May 2010
Date type not reportedThis date has not been verified as actual or estimated.
Early Placental Insufficiency Screening
Contact the study team to confirm eligibility.
Primary Completion
June 2014
Actual (reported)Study Completion
June 2014
Actual (reported)Last Updated
December 18, 2014
Record last verified: 2014-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: